{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:19:28Z","timestamp":1788175168076,"version":"build-2803163510"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>\n                    A variety of commercially available urinary molecular markers have been introduced for detecting and monitoring urothelial carcinoma (UC). We prospectively evaluated the UroVysion\n                    <jats:sup>TM<\/jats:sup>\n                    Bladder Cancer Kit (FISH) and the Xpert\u00ae Bladder Cancer Detection (Xpert) test. Both tests were performed on voided urine samples after negative cystoscopy and negative abdominal ultrasound (US) and\/or negative computed tomography urography (CTU). Urine specimens from 156 patients diagnosed with hematuria and suspected of having UC and 48 patients followed up after treatment of UC were analyzed using FISH and Xpert. Among 204 patients, 20 had UC, 11 located in the bladder, six in the ureter, and three in the renal pelvis. FISH had an overall sensitivity (SN) of 78%, a specificity (SP) of 93%, and a negative predictive value (NPV) of 96%. Xpert had an overall SN of 90%, an SP of 85%, and an NPV of 98%. Both tests had high SN, SP, and NPV. The SP of FISH was significantly higher. By using FISH and Xpert in addition to cystoscopy, renal and bladder US, and\/or CTU in the diagnostic workup of patients with hematuria and follow-up after transurethral resection of the bladder (TURB), a substantial number of patients (10%) otherwise missed were discovered to have UC.\n                  <\/jats:p>","DOI":"10.3389\/fgene.2022.839598","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:42:38Z","timestamp":1654476158000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical Evaluation of Two Non-Invasive Genetic Tests for Detection and Monitoring of Urothelial Carcinoma: Validation of UroVysion and Xpert Bladder Cancer Detection Test"],"prefix":"10.3389","volume":"13","author":[{"given":"Niko","family":"Kavcic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Peric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreja","family":"Zagorac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Kokalj Vokac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur. Urol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/j.1464-410X.2005.05509.x","article-title":"Quantitative Molecular Urinary Cytology by Fluorescence In Situ Hybridization: a Tool for Tailoring Surveillance of Patients with Superficial Bladder Cancer?","volume":"95","author":"Bollmann","year":"2005","journal-title":"BJU Int."},{"key":"B3","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.eururo.2013.03.059","article-title":"Photodynamic Diagnosis of Non-muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-Analysis of Detection and Recurrence Based on Raw Data","volume":"64","author":"Burger","year":"2013","journal-title":"Eur. Urol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1089\/end.2008.0096","article-title":"Is There a Role for FISH in the Management and Surveillance of Patients with Upper Tract Transitional-Cell Carcinoma?","volume":"22","author":"Chen","year":"2008","journal-title":"J. Endourology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/bju.15418","article-title":"Longitudinal Follow\u2010up and Performance Validation of an mRNA\u2010based Urine Test (Xpert Bladder Cancer Monitor ) for Surveillance in Patients with Non\u2010muscle\u2010invasive Bladder Cancer","volume":"128","author":"Cowan","year":"2021","journal-title":"BJU Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nrurol.2012.32","article-title":"CT Urography for Hematuria","volume":"9","author":"Cowan","year":"2012","journal-title":"Nat. Rev. Urol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/cncy.21327","article-title":"Evaluation of Urovysion and Cytology for Bladder Cancer Detection","volume":"121","author":"Dimashkieh","year":"2013","journal-title":"Cancer Cytopathol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.urolonc.2010.08.006","article-title":"The Role of FISH and Cytology in Upper Urinary Tract Surveillance after Radical Cystectomy for Bladder Cancer","volume":"30","author":"Fern\u00e1ndez","year":"2012","journal-title":"Urologic Oncol. Seminars Orig. Investigations"},{"key":"B9","first-page":"8620","article-title":"Fluorescence In Situ Hybridization (FISH) in the Diagnosis of Bladder and Upper Tract Urothelial Carcinoma: the Largest Single-Institution Experience to Date","volume":"24","author":"Gomella","year":"2017","journal-title":"Can. J. Urol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.urology.2019.01.011","article-title":"The Prevalence of Bladder Cancer during Cystoscopy for Asymptomatic Microscopic Hematuria","volume":"126","author":"Gonzalez","year":"2019","journal-title":"Urology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s11255-014-0714-1","article-title":"FISH Analysis of Washing Urine from the Upper Urinary Tract for the Detection of Urothelial Cancers","volume":"46","author":"Gruschwitz","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.urolonc.2007.06.002","article-title":"UroVysion FISH Test for Detecting Urothelial Cancers: Meta-Analysis of Diagnostic Accuracy and Comparison with Urinary Cytology Testing","volume":"26","author":"Hajdinjak","year":"2008","journal-title":"Urologic Oncol. Seminars Orig. Investigations"},{"key":"B13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/PAP.0b013e3181832320","article-title":"Bladder Cancer Detection Using FISH (UroVysion Assay)","volume":"15","author":"Halling","year":"2008","journal-title":"Adv. Anat. Pathol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur. Urol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1002\/cncr.24339","article-title":"Carcinoma of the Upper Urinary Tract","volume":"115","author":"Inman","year":"2009","journal-title":"Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.2214\/AJR.10.5249","article-title":"Comparison of CT Urography and Excretory Urography in the Detection and Localization of Urothelial Carcinoma of the Upper Urinary Tract","volume":"196","author":"Jinzaki","year":"2011","journal-title":"Am. J. Roentgenol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.juro.2010.05.023","article-title":"Voided Urine Fluorescence In Situ Hybridization Testing for Upper Tract Urothelial Carcinoma Surveillance","volume":"184","author":"Johannes","year":"2010","journal-title":"J. Urology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"23880","DOI":"10.18632\/oncotarget.13054","article-title":"Narrow Band Imaging-Assisted Transurethral Resection Reduces the Recurrence Risk of Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis","volume":"8","author":"Kang","year":"2017","journal-title":"Oncotarget"},{"key":"B19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.eururo.2006.08.045","article-title":"Utility of Fluorescence In Situ Hybridization as a Non-invasive Technique in the Diagnosis of Upper Urinary Tract Urothelial Carcinoma","volume":"51","author":"Mar\u00edn-Aguilera","year":"2007","journal-title":"Eur. Urol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1309\/AJCPE1O9YKMRSQKG","article-title":"Accuracy and Interobserver Variability of the Cytologic Diagnosis of Low-Grade Urothelial Carcinoma in Instrumented Urinary Tract Cytology Specimens","volume":"144","author":"McCroskey","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/dc.24108","article-title":"Comparison of Urinary Cytology and Fluorescence In Situ Hybridization in the Detection of Urothelial Neoplasia: An Analysis of Discordant Results","volume":"47","author":"McHale","year":"2019","journal-title":"Diagn Cytopathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.eururo.2010.04.026","article-title":"Fluorescence In Situ Hybridisation in the Diagnosis of Upper Urinary Tract Tumours","volume":"58","author":"Mian","year":"2010","journal-title":"Eur. Urol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta14040","article-title":"Systematic Review of the Clinical Effectiveness and Cost-Effectiveness of Photodynamic Diagnosis and Urine Biomarkers (FISH, ImmunoCyt, NMP22) and Cytology for the Detection and Follow-Up of Bladder Cancer","volume":"14","author":"Mowatt","year":"2010","journal-title":"Health Technol. Assess."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.21037\/tau-20-1207","article-title":"UroVysion Fluorescence In Situ Hybridization in Urothelial Carcinoma: a Narrative Review and Future Perspectives","volume":"10","author":"Nagai","year":"2021","journal-title":"Transl. Androl. Urol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","article-title":"Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers","volume":"73","author":"Paner","year":"2018","journal-title":"Eur. Urol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/bju.14019","article-title":"Increased Accuracy of a Novel mRNA-Based Urine Test for Bladder Cancer Surveillance","volume":"121","author":"Pichler","year":"2018","journal-title":"BJU Int."},{"key":"B27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0302-2838(02)00006-4","article-title":"Differences between Local and Review Urinary Cytology in Diagnosis of Bladder Cancer. An Interobserver Multicenter Analysis","volume":"41","author":"Raitanen","year":"2002","journal-title":"Eur. Urol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/bju.13345","article-title":"Microscopic Haematuria at Time of Diagnosis Is Associated with Lower Disease Stage in Patients with Newly Diagnosed Bladder Cancer","volume":"117","author":"Ramirez","year":"2016","journal-title":"BJU Int."},{"key":"B29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/cncy.21414","article-title":"Comparison of Urine Cytology and Fluorescence In Situ Hybridization in Upper Urothelial Tract Samples","volume":"122","author":"Reynolds","year":"2014","journal-title":"Cancer Cytopathol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","article-title":"European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update","volume":"79","author":"Roupr\u00eat","year":"2021","journal-title":"Eur. Urol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s00345-014-1452-9","article-title":"Multicenter Evaluation of the Role of UroVysion FISH Assay in Surveillance of Patients with Bladder Cancer: Does FISH Positivity Anticipate Recurrence?","volume":"33","author":"Seideman","year":"2015","journal-title":"World J. Urol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.urolonc.2021.08.017","article-title":"Xpert Bladder Cancer Monitor in Surveillance of Bladder Cancer: Systematic Review and Meta-Analysis","volume":"40","author":"Sharma","year":"2022","journal-title":"Urologic Oncol. Seminars Orig. Investigations"},{"key":"B33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer Statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA A Cancer J. Clin."},{"key":"B34","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2478\/raon-2020-0072","article-title":"The Performance of the Xpert Bladder Cancer Monitor Test and Voided Urinary Cytology in the Follow-Up of Urinary Bladder Tumors","volume":"55","author":"Smrkolj","year":"2020","journal-title":"Radiol. Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.urology.2005.02.003","article-title":"Correlation of Office-Based Cystoscopy and Cytology with Histologic Diagnosis: How Good Is the Reference Standard?","volume":"66","author":"Svatek","year":"2005","journal-title":"Urology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1038\/modpathol.2008.193","article-title":"Diagnosis of Urothelial Carcinoma from Urine","volume":"22","author":"T\u00eatu","year":"2009","journal-title":"Mod. Pathol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.euo.2020.09.001","article-title":"Validation of an MRNA-Based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria","volume":"4","author":"Valenberg","year":"2021","journal-title":"Eur. Urol. Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.eururo.2018.11.055","article-title":"Prospective Validation of an mRNA-Based Urine Test for Surveillance of Patients with Bladder Cancer","volume":"75","author":"Valenberg","year":"2019","journal-title":"Eur. Urol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.juro.2017.09.141","article-title":"Development of a 90-Minute Integrated Noninvasive Urinary Assay for Bladder Cancer Detection","volume":"199","author":"Wallace","year":"2018","journal-title":"J. Urology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1016\/j.urolonc.2014.06.008","article-title":"Prospective Analysis of Sensitivity and Specificity of Urinary Cytology and Other Urinary Biomarkers for Bladder Cancer","volume":"33","author":"Yafi","year":"2015","journal-title":"Urologic Oncol. Seminars Orig. Investigations"},{"key":"B41","first-page":"1","article-title":"Biomarkers for Bladder Cancer Management: Present and Future","volume":"2","author":"Ye","year":"2014","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/ijc.21704","article-title":"Multi-target Fluorescencein Situ Hybridization in Bladder Washings for Prediction of Recurrent Bladder Cancer","volume":"119","author":"Zellweger","year":"2006","journal-title":"Int. J. Cancer"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.839598\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:42:44Z","timestamp":1654476164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.839598\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,6]]},"references-count":42,"alternative-id":["10.3389\/fgene.2022.839598"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.839598","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,6]]},"article-number":"839598"}}